LENSAR Reports Second Quarter 2021 Financial Results and Provides Business Update

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2021 and provided an update on key strategic and operational initiatives. “We have made significant progress across a number of fronts. Our commercial operations have rebounded from the COVID-19 pandemic, and we have ret

Full Story →